Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.

About Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.

A leading High-end Pharmaceutical Injectables manufacturer from China with over 60 ANDAs approved in USA. Top 3 supplier of Heparin and Enoxaparin APIs across the globe. 
Top exporter from China to US of Injetables with over 250 Million USD revenue per year.
Two manufacturing sites for Injectables and one API manufacturing site accrediated with USFDA,  EMA, PMDA. 

Certifications
  • Country/Region:
    China
  • On CPHI since:
    2022
  • Certificates:
    2
  • Employees:
    1000 - 4999
Company types
Biopharmaceutical company
CMO/CDMO
Generics/Biosimilars Manufacturer
Pharmaceutical company
Primary activities
Biopharmaceutical
Pharmaceutical Company (generic finished products)
Contact info
  • 16 Xuefu Road,High&New Tech Development Zone, 21006, Nanjing, J.S., China
Meet us at

CPHI & PMEC China 2026

Shanghai New International Expo Center
16 Jun 2026 - 18 Jun 2026

CPHI South East Asia 2026

QSNCC, Bangkok, Thailand
08 Jul 2026 - 10 Jul 2026

CPHI Korea 2026

COEX, Seoul, Korea
25 Aug 2026 - 27 Aug 2026

CPHI Milan 2026

Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026

Products from Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. (1)

  • Heparin Sodium/ Enoxaparin Sodium

    Product Heparin Sodium/ Enoxaparin Sodium

    API and FDF both Approved in US, EU, China, Brazil US GMP, EU GMP, Japan GMP, China GMP, Brazil GMP, Mexico GMP available. World’s most stable supply, best quality, competitive price.